JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.12103
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Evaluation on Thrombotic Events Frequency in JAK2 V617F Positive Patients

Journal of Hematology & Thromboembolic Diseases
2017English

Kronik Miyeloproliferatif Hastalık Olgularında JAK2 V617F Mutasyon Sıklığı

Harran Üniversitesi Tıp Fakültesi Dergisi
2019English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Absence of the JAK2 V617F Activating Mutation in Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins

The Open Enzyme Inhibition Journal
2009English

Sensitive PCR-based Monitoring and Early Detection of Relapsed JAK2 V617F Myelofibrosis Following Transplantation

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy